Bicocca Open Archive

Logo unimib boa
POGLIANI, ENRICO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.613
EU - Europa 4.530
AS - Asia 4.494
SA - Sud America 807
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 9
Totale 20.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.357
SG - Singapore 1.616
CN - Cina 1.276
HK - Hong Kong 868
DE - Germania 788
RU - Federazione Russa 742
BR - Brasile 654
SE - Svezia 638
IE - Irlanda 612
UA - Ucraina 549
IT - Italia 490
VN - Vietnam 271
GB - Regno Unito 238
CA - Canada 204
FI - Finlandia 136
IN - India 114
KR - Corea 99
FR - Francia 81
AR - Argentina 57
JP - Giappone 47
NL - Olanda 46
AT - Austria 42
ZA - Sudafrica 42
EC - Ecuador 40
BD - Bangladesh 39
TR - Turchia 35
DK - Danimarca 34
MX - Messico 34
PL - Polonia 29
BE - Belgio 28
IQ - Iraq 27
ES - Italia 24
ID - Indonesia 21
EU - Europa 14
MA - Marocco 13
CO - Colombia 12
PK - Pakistan 12
PY - Paraguay 12
LT - Lituania 11
SA - Arabia Saudita 11
EG - Egitto 10
CL - Cile 9
VE - Venezuela 9
BG - Bulgaria 8
UY - Uruguay 8
AU - Australia 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
KE - Kenya 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
TN - Tunisia 5
IL - Israele 4
IR - Iran 4
JO - Giordania 4
MY - Malesia 4
NP - Nepal 4
PT - Portogallo 4
ET - Etiopia 3
HU - Ungheria 3
MK - Macedonia 3
PA - Panama 3
PE - Perù 3
TH - Thailandia 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
CH - Svizzera 1
CR - Costa Rica 1
CU - Cuba 1
EE - Estonia 1
FJ - Figi 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
MZ - Mozambico 1
NI - Nicaragua 1
Totale 20.551
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.839
Woodbridge 1.038
Hong Kong 868
Ashburn 857
Singapore 832
Houston 748
Fairfield 647
Dublin 599
Jacksonville 588
Chandler 457
Frankfurt am Main 390
Wilmington 373
Dearborn 323
New York 287
Seattle 258
Princeton 224
Cambridge 207
Beijing 198
Los Angeles 153
Milan 150
Hefei 142
Santa Clara 134
Nanjing 129
Shanghai 119
Lawrence 103
Lachine 102
Altamura 100
Seoul 96
Ho Chi Minh City 88
Dallas 86
Moscow 77
Buffalo 72
Chicago 66
The Dalles 65
Hanoi 62
São Paulo 62
Göttingen 52
Guangzhou 44
Nanchang 42
Changsha 40
Andover 37
Toronto 35
San Diego 34
Vienna 33
Shenyang 32
Ottawa 29
Brussels 28
Hebei 28
Tokyo 28
London 27
Munich 27
Warsaw 24
Boardman 23
Rio de Janeiro 23
Huizen 22
Helsinki 21
Atlanta 20
Johannesburg 20
Salt Lake City 19
Denver 18
Fürstenwalde 18
Jiaxing 18
Jinan 18
Tampa 18
Tianjin 18
Fremont 17
Montreal 17
Hangzhou 16
Lissone 16
Norwalk 16
Orem 16
Redmond 16
Chennai 15
Council Bluffs 15
Nürnberg 15
Pune 15
San Jose 15
University Park 15
Zhengzhou 15
Brooklyn 14
Boston 13
Haiphong 13
Kunming 13
Mountain View 13
Poplar 13
Guayaquil 12
New Delhi 12
Turku 12
Campinas 11
Elk Grove Village 11
Rome 11
Stockholm 11
Brasília 10
Manchester 10
Porto Alegre 10
Quito 10
San Francisco 10
Curitiba 9
Dhaka 9
Falls Church 9
Totale 13.790
Salva come PNG Salva come JPEG
Nome #
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 494
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 423
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia 421
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib 387
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 381
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 353
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 336
Imatinib long term effects study: three years of follow-up and assessment 336
A boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation 331
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 314
Good outcome for very high risk adult B-cell acute lymphoblastic leukaemia carrying genetic abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if promptly submitted to allogeneic transplantation, after obtaining a good molecular remission 309
Thrombosis of the splenoportal axis after splenectomy 268
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: A phase I study 258
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 255
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 249
Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis 249
A CASE OF ATYPICAL PROLONGED HEMATOLOGIC TOXICITY WITH AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), REVIEW OF LITERATURE AND A PROPOSAL OF MANAGEMENT 248
Severe, reversible nelarabine-induced neuropathy and myelopathy 248
Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report 245
A prospective study on cardiovascular events after acute pulmonary embolism 236
Circulating endothelial cells and endothelial activation in essential thrombocythemia: Results from CD146(+) immunomagnetic enrichment-flow cytometry and soluble E-selectin detection 236
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 235
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma 221
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study) 220
Combined prophylactic low-molecular weight heparin and low dose aspirin reduces the occurrences of adverse pregnancy outcome in multiparous women with preeclampsia and intrauterine fetal growth restriction in antecedent pregnancy 218
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 216
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease 216
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 215
Recurrent preeclapsia: The role of acquired and heritable thrombophilia 214
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry 214
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination 207
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies 206
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone 203
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 203
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN 203
Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy 203
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: A case report 201
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 200
NPM/ALK binds and phosphorylates the RNA/DNA binding protein PSF in anaplastic large cell lymphoma 197
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 197
High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study 196
Autoimmune hepatitis presenting as imatinib toxicity: description of a case and of therapeutic alternatives 196
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) 196
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance 188
Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? 185
Platelet activation during plasma-reduced multicomponent PLT collection: A comparison between COBE Trima and Spectra LRS turbo cell separators 184
Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy 182
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 182
Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease 181
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 180
Crizotinib in anaplastic large-cell lymphoma 180
Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group 179
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial 177
Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect 176
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: A randomized study 175
Prevention of venous thromboembolism in immobilized neurological patients: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 174
Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds 172
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients 172
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL) 167
Resistance Profile of the BCR/ABL Inhibitor Bosutinib Using a High Throughput random Mutagenesis Assay 167
Reviewed diagnosis of primary and secondary immune thrombocytopenic purpura in 79 adult patients hospitalized in 2000 - 2002 166
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies 165
Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 162
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned 161
Venous thromboembolism and cancer: Guidelines of the Italian Association of Medical Oncology (AIOM) 160
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials 159
Chemotherapy-phased imatinib pulses improve long-term outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: Northern Italy Leukemia Group protocol 09/00 158
Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenström's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: Proposal for a common prognostic scoring system 156
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11) 155
A case of Philadelphia Positive Acute Lymphoblastic Leukaemia with three different phenotypic lineage, each one presenting the same BCR-ABL hybrid transcript 152
Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia 152
HOMOZYGOSITY FOR JAK2V617F IDENTIFIES MPD PATIENTS WITH A MORE SYMPTOMATIC DISEASE A RETROSPECTIVE STUDY ON 989 PATIENTS FROM THE GIMEMA-MPD WORKING PARTY 152
Development of c-Kit-expressing Small-Cell lung Cancer in a Chronic Myeloid Leukemia Patient During Imatinib Treatment 151
SIGNIFICANT REDUCTION IN FASTING BLOOD GLUCOSE IN NONDIABETIC PH+ CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB MESYLATE 147
Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program 146
Fully immunocompetent CD8+ T lymphocytes are present in autologous haematopoietic stem cell transplantation recipients despite an ineffectual T-helper response 142
Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: A prospective multicentre study 141
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes 141
From Vaquez to Dameshek through JAK…2 much for polycythemia vera to be feared? 141
Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: case-control study in patients with multiple myeloma and review of the literature 139
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 139
Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD 138
Advanced mast cell disease: an Italian Hematological Multicenter experience 137
Atypical presentation of Upshaw-Schulman syndrome in a pregnant patient homozygous for V Leiden mutation 134
Imatinib concentrations in human milk 130
Primary plasma cell leukemia: a retrospective multicenter study of 73 patients 129
Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions 129
Corticosteroids can reverse severe imatinib-induced hepatotoxicity 128
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma 126
Peripheral blood progenitor cell collection in chronic myeloid leukemia patients with complete cytogenetic response after treatment with imatinib mesylate 123
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage 123
Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia 123
Allogeneic stem cell transplantation following reduced-intensity conditioning can induce durable clinical and molecular remissions in relapsed lymphomas: pre-transplant disease status and histotype heavily influence outcome 122
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21 121
Low Efficiency of a Newly Introduced High-Density Microparticles Method for B Cell Depletion in Multiple Myeloma Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation 121
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: Incidence, risk factors, and effect of treatments 120
In reply to 'Cardiotoxicity of the cancer therapeutic agent imatinib mesylate' [2] 118
Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patients 118
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study 116
Mast cell leukemia: A report of ten cases 115
Totale 19.731
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.472
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021883 0 0 0 0 0 108 168 100 176 180 66 85
2021/20221.088 50 58 90 111 85 103 42 85 71 92 106 195
2022/20232.038 293 671 195 163 127 311 17 79 109 6 34 33
2023/20241.665 38 45 54 78 244 490 341 47 174 13 21 120
2024/20253.085 211 356 120 138 296 75 122 75 319 462 312 599
2025/20264.343 764 566 669 953 969 422 0 0 0 0 0 0
Totale 20.881